{"transactions":[{"id":3092687,"issuer":{"id":5982,"kind":"organization","name":"NORTHWEST BIOTHERAPEUTICS INC"},"owners":[{"id":148070,"kind":"person","name":"Goldman Leslie J.","position":1,"cik":"0001742619","reported_name":"Goldman Leslie J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Options to purchase Common Stock, par value $0.001","published_at":"2020-07-03T01:55:48.000Z","date":"2020-07-02","kind":"grant","acquired":true,"shares":5415952,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These options were approved in January 2020.  The exercise price was determined based upon the pricing in year-end financings with unrelated investors.  However, these options have not been executed and implemented (granted) until now."}],"balance_after":5415952,"derivative":{"exercise_price":0.21,"exercise_date":"2020-07-02","expiration_date":"2030-07-02","underlying":"Common Stock, par value $0.001","underlying_shares":5415952},"source":{"system":"sec-edgar","filing":"0001104659-20-080812","document":"tm2022243d12_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1072379/000110465920080812/tm2022243d12_4.xml","form_type":"4"}},{"id":3092686,"issuer":{"id":5982,"kind":"organization","name":"NORTHWEST BIOTHERAPEUTICS INC"},"owners":[{"id":148070,"kind":"person","name":"Goldman Leslie J.","position":1,"cik":"0001742619","reported_name":"Goldman Leslie J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Options to purchase Common Stock, par value $0.001","published_at":"2020-07-03T01:55:48.000Z","date":"2020-07-02","kind":"grant","acquired":true,"shares":1315566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These options were already approved and publicly reported in 2018. The exercise price was determined with reference to the pricing for unrelated investors at that time. However, the documents to implement and issue (grant) them have not been executed until now."}],"balance_after":1315566,"derivative":{"exercise_price":0.25,"exercise_date":"2020-07-02","expiration_date":"2030-07-02","underlying":"Common Stock, par value $0.001","underlying_shares":1315566},"source":{"system":"sec-edgar","filing":"0001104659-20-080812","document":"tm2022243d12_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1072379/000110465920080812/tm2022243d12_4.xml","form_type":"4"}},{"id":3092685,"issuer":{"id":5982,"kind":"organization","name":"NORTHWEST BIOTHERAPEUTICS INC"},"owners":[{"id":148070,"kind":"person","name":"Goldman Leslie J.","position":1,"cik":"0001742619","reported_name":"Goldman Leslie J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Options to purchase Common Stock, par value $0.001","published_at":"2020-07-03T01:55:48.000Z","date":"2020-07-02","kind":"grant","acquired":true,"shares":21822937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These options were awarded in part for service during the last 2 years. However, the documents to implement and issue (grant) them have not been executed until now. The $0.25 exercise price was determined with reference to the pricing for unrelated investors at the time of approval, which was the trailing 10-day average closing market price of the Company's stock, which was about $0.22. These options are subject to certain vesting requirements. They are also suspended and will not become exercisable until December 1, 2020."}],"balance_after":21822937,"derivative":{"exercise_price":0.25,"exercise_date":"2020-12-01","expiration_date":"2030-12-01","underlying":"Common Stock, par value $0.001","underlying_shares":21822937},"source":{"system":"sec-edgar","filing":"0001104659-20-080811","document":"tm2022243d11_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1072379/000110465920080811/tm2022243d11_4.xml","form_type":"4"}},{"id":3891211,"issuer":{"id":5982,"kind":"organization","name":"NORTHWEST BIOTHERAPEUTICS INC"},"owners":[{"id":148070,"kind":"person","name":"Goldman Leslie J.","position":1,"cik":"0001742619","reported_name":"Goldman Leslie J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Options to purchase Common Stock, par value $0.001","published_at":"2018-06-19T00:00:41.000Z","date":"2018-05-28","kind":"grant","acquired":true,"shares":24500000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"19,600,000 of these 24,500,000 Options were previously reported on Form 8-K on January 16, 2018, following Board approval. Half of the Options are vested at the time of issuance and half will vest monthly over the course of 24 months from the date of Board approval, subject to acceleration in certain circumstances."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The exercise price of the Options is $0.23."}],"balance_after":24500000,"derivative":{"exercise_price":0.23,"exercise_date":"2018-05-28","expiration_date":"2028-05-28","underlying":"Common Stock, par value $0.001","underlying_shares":24500000},"source":{"system":"sec-edgar","filing":"0001144204-18-034675","document":"tv495291_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1072379/000114420418034675/tv495291_4.xml","form_type":"4"}}]}